CXCL12 and cancer: It also been pointed that activation of CXCL12-CXCR4 axis in MSCs reduces imatinib-induced cell death in chronic myeloid leukemia [104], or protect cancer cells from hyperthermia-induced cell death induced by intraperitoneal chemotherapy in ovarian cancer cells [105].